Stifel, Cytokinetics
Stifel analysts kept a Buy rating on Revolve Group (NYSE:RVLV) shares, maintaining a $41.00 price target. The firm is ...
Stifel initiated coverage on Cytokinetics Incorporated (NASDAQ:CYTK), noting the company’s catalyst rich one to two years.
Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...
Wall Street analysts are buzzing with optimism as we step into 2025. There are plenty of reasons for a positive view to ...
Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.
Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback